Seminars in major European cities are being organized by the EUropeanUnion to study and report on the "vital question" of intellectual property protection in Southeast Asia. The seminars mark the completion of the EU-Association of Southeast Asian Nations patent and trade mark program. The objective of the program, which has a 6.5 million Ecu ($7.3 million) budget, is the modernization and improvement of the patent and trade mark administration in ASEAN countries. The issues especially concern the pharmaceutical industry.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze